http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115006396-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 |
| filingDate | 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd46a09baeab37f3fa3772ac54c51170 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bb135b3ace9688bae49ba140abb7d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddff4b35fb870cb87f8f833191223909 |
| publicationDate | 2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115006396-A |
| titleOfInvention | The use of lysinine in the preparation of medicines for the prevention and treatment of anhedonia-type depression |
| abstract | The present invention provides the use of liensinine in preparing a medicine for preventing and treating anhedonia type depression. Methyl lysinine can increase the content of depression-related factors in the hippocampus, protect the structure and function of the hippocampus, and regulate the intestinal flora to improve depressive behavior, especially for the prevention and treatment of anhedonia. Medications for type depression offer a new option. |
| priorityDate | 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.